DCPH - Deciphera Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - DCPH (1654151)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
47 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-02-16
DCPHSherman Matthew LEVP, Chief Medical OfficerS - Sale+OE$15.62-2,615108,739-2%-$40,840
D
2024-02-16
DCPHKelly Thomas PatrickCFOS - Sale+OE$15.62-3,01080,350-4%-$47,009
D
2024-02-16
DCPHPitman JamaSVP, Chief Development OfficerS - Sale+OE$15.62-2,26768,031-3%-$35,405
D
2024-02-16
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale+OE$15.62-2,26755,118-4%-$35,405
2024-01-16
DCPHSherman Matthew LEVP, Chief Medical OfficerS - Sale$14.47-2,43594,079-3%-$35,234
2024-01-16
DCPHPitman JamaSVP, Chief Development OfficerS - Sale$14.47-1,62450,573-3%-$23,499
2024-01-16
DCPHKelly Thomas PatrickCFOS - Sale$14.47-2,43566,085-4%-$35,234
2024-01-16
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale$14.47-1,62447,660-3%-$23,499
2023-12-13
DCPHHoerter Steven L.Pres, CEOS - Sale$15.37-30,66472,763-30%-$471,217
2023-12-13
DCPHKelly Thomas PatrickCFOS - Sale$15.37-2,79268,520-4%-$42,905
2023-12-13
DCPHPitman JamaSee RemarksS - Sale$15.37-1,66252,197-3%-$25,540
2023-12-13
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale$15.37-1,72749,284-3%-$26,539
2023-12-13
DCPHSherman Matthew LEVP, Chief Medical OfficerS - Sale$15.37-2,79296,514-3%-$42,905
2023-11-30
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale$12.57-17,80145,435-28%-$223,755
2023-10-30
DCPHSherman Matthew LEVP, Chief Medical OfficerS - Sale$12.02-2,36090,628-3%-$28,362
2023-10-30
DCPHPitman JamaSee RemarksS - Sale$12.02-1,40748,283-3%-$16,909
2023-10-30
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale$12.02-1,40762,884-2%-$16,909
2023-10-30
DCPHKelly Thomas PatrickCFOS - Sale$12.02-2,31663,068-4%-$27,833
2023-10-30
DCPHHoerter Steven L.Pres, CEOS - Sale$12.02-21,57340,927-35%-$259,256
2023-10-02
DCPHSherman Matthew LEVP, Chief Medical OfficerS - Sale$12.68-2,94284,744-3%-$37,305
2023-06-16
DCPHPitman JamaSee RemarksS - Sale$14.40-1,23843,812-3%-$17,829
2023-06-16
DCPHSherman Matthew LEVP, Chief Medical OfficerS - Sale$14.40-1,65587,686-2%-$23,835
2023-06-16
DCPHKelly Thomas PatrickCFOS - Sale$14.40-1,65557,140-3%-$23,835
2023-06-16
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale$14.40-1,23858,413-2%-$17,829
2023-06-16
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale$14.40-1,655378,6130%-$23,835
2023-06-08
DCPHFriedman Franklin StuartDirP - Purchase$13.88+10,00010,000New+$138,828
2023-05-10
DCPHWalsh Dennis LeoDirP - Purchase$13.86+11,00011,000New+$152,416
2023-03-21
DCPHHoerter Steven L.Pres, CEOS - Sale$15.57-7,5000-100%-$116,782
D
2023-02-16
DCPHPitman JamaSee RemarksS - Sale+OE$15.10-1,15945,050-3%-$17,500
D
2023-02-16
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale+OE$15.10-1,15958,381-2%-$17,500
D
2023-02-16
DCPHKelly Thomas PatrickCFOS - Sale+OE$15.10-1,37058,795-2%-$20,686
D
2023-02-16
DCPHSherman Matthew LEVP, Chief Medical OfficerS - Sale+OE$15.10-97188,145-1%-$14,661
D
2023-02-16
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale+OE$15.10-1,370380,2680%-$20,686
D
2023-02-14
DCPHHoerter Steven L.Pres, CEOS - Sale+OE$16.00-30,0457,500-80%-$480,720
2023-01-24
DCPHBrightstar Associates LLC10%P - Purchase$18.00+1,666,66619,718,014+9%+$29,999,988
2023-01-17
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale$21.24-2,403365,150-1%-$51,043
2023-01-17
DCPHPitman JamaSee RemarksS - Sale$21.24-1,60335,058-4%-$34,050
2023-01-17
DCPHSherman Matthew LEVP, Chief Medical OfficerS - Sale$21.24-2,40372,628-3%-$51,043
2023-01-17
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale$21.24-1,60348,389-3%-$34,050
2023-01-17
DCPHKelly Thomas PatrickCFOS - Sale$21.24-2,40343,677-5%-$51,043
2022-10-03
DCPHSherman Matthew LEVP, Chief Medical OfficerS - Sale$18.73-2,58774,297-3%-$48,455
2022-06-16
DCPHSherman Matthew LEVP, Chief Medical OfficerS - Sale$10.75-1,76876,884-2%-$19,006
2022-06-16
DCPHPitman JamaSee RemarksS - Sale$10.75-1,29836,661-3%-$13,954
2022-06-16
DCPHMartin Daniel C.Chief Commercial OfficerS - Sale$10.75-1,31149,521-3%-$14,093
2022-06-16
DCPHKelly Thomas PatrickCFOS - Sale$10.75-1,76846,080-4%-$19,006
2022-06-16
DCPHFlynn Daniel LeeChief Scientific OfficerS - Sale$10.75-1,768367,5530%-$19,006
D
2022-04-29
DCPHBrightstar Associates LLC10%P - Purchase$10.00+1,478,97818,051,348+9%+$14,789,780

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top